Login / Signup

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.

Anat AchironMathilda MandelSapir Dreyer-AlsterGil HarariDavid MagalashviliPolina SonisMark DolevShay MenascuShlomo FlechterRina FalbMichael Gurevich
Published in: Therapeutic advances in neurological disorders (2021)
Keyphrases
  • immune response
  • coronavirus disease
  • sars cov
  • dendritic cells
  • toll like receptor
  • binding protein
  • respiratory syndrome coronavirus